Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants.
Jay Rubinstein, MD, PhD
Advertisement
Articles by Jay Rubinstein, MD, PhD
Advertisement
Latest Updated Articles
Jay Rubinstein, MD, PhD, explains DB-OTO gene therapy in children with profound hearing lossPublished: March 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Meta-analysis finds vegetarian and vegan diets can support healthy growth in children
2
FDA calls for improved retail recall compliance to protect infants and young children
3
Rationale for supporting the birth dose of hepatitis B vaccine for all newborns
4
Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests
5
